SLE Survival Rates Improving, But Lupus Nephritis Risk High Among Non-White Patients
Researchers investigated the patient factors that affect risk for mortality and lupus nephritis among patients with SLE.
Researchers investigated the patient factors that affect risk for mortality and lupus nephritis among patients with SLE.
Researchers investigated the use of ultrasound-defined tenosynovitis in predicting the persistence of inflammatory arthritis.
A team of researchers performed an integrated safety analysis from 4 clinical trials among patients with psoriatic arthritis to assess the safety profile of ixekizumab.
Researchers compared the sensitivity and specificity of the EULAR/ACR 2019 classification criteria with prior classification criteria among patients with childhood-onset systemic lupus erythematosus.
Using data from the COVID-19 Global Rheumatology Alliance, researchers studied the clinical characteristics of patients with rheumatic disease who developed SARS-CoV-2 breakthrough infections.
Authors of a systematic review compared the efficacy and safety of systemic therapies in the treatment of manifestations of active psoriatic arthritis.
Researchers aimed to study the outcomes of patients with systemic lupus erythematosus diagnosed during hospitalization.
The aim of the study was to determine the effect of psoriatic arthritis therapy on COVID-19 vaccination response.
Significantly more patients with JIA stopped taking their medications over a period of 18 vs 8 years after disease onset.
Researchers investigated the effect of remission and lupus low disease activity state on health-related quality of life in patients with systemic lupus erythematosus.